The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

21 articles for PC Lv


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.EBI
Nanjing University
Synthesis, biological evaluation and 3D-QSAR studies of novel 5-phenyl-1H-pyrazol cinnamamide derivatives as novel antitubulin agents.EBI
Nanjing University
6,7-Dihydrobenzo[f]benzo[4,5]imidazo[1,2-d][1,4]oxazepine derivatives as selective inhibitors of PI3Ka.EBI
Nanjing University
Design, synthesis and biological evaluation of (E)-3-(3,4-dihydroxyphenyl)acrylylpiperazine derivatives as a new class of tubulin polymerization inhibitors.EBI
Nanjing University
Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAF(V600E) inhibitors.EBI
Nanjing University
Aromatic diacylhydrazine derivatives as a new class of polo-like kinase 1 (PLK1) inhibitors.EBI
Nanjing University
Design, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.EBI
Purdue University
Synthesis and biological evaluation of pyrazole derivatives containing thiourea skeleton as anticancer agents.EBI
Nanjing University
Synthesis and antitumor activity of 1,2,4-triazoles having 1,4-benzodioxan fragment as a novel class of potent methionine aminopeptidase type II inhibitors.EBI
Nanjing University
Synthesis, molecular docking and evaluation of thiazolyl-pyrazoline derivatives as EGFR TK inhibitors and potential anticancer agents.EBI
Nanjing University
The combination of 4-anilinoquinazoline and cinnamic acid: a novel mode of binding to the epidermal growth factor receptor tyrosine kinase.EBI
Nanjing University
Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.EBI
Nanjing University
Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line.EBI
Nanjing University
Design, synthesis and biological evaluation of chrysin long-chain derivatives as potential anticancer agents.EBI
Nanjing University
Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors.EBI
Nanjing University
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.EBI
Nanjing University
Discovery and development of novel rhodanine derivatives targeting enoyl-acyl carrier protein reductase.EBI
Nanjing University
Design, synthesis and evaluation of novel diaryl-1,5-diazoles derivatives bearing morpholine as potent dual COX-2/5-LOX inhibitors and antitumor agents.EBI
Nanjing University
Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors.EBI
Nanjing University
Amines and oximes derived from deoxybenzoins as Helicobacter pylori urease inhibitors.EBI
Nanjing University
Functional characterisation of the human cloned 5-HT7 receptor (long form); antagonist profile of SB-258719.BDB
Smithkline Beecham Pharmaceuticals